# US 11,993,804 B2 · Generic sample preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,993,804 B2
- Document ID: US11993804B2
- Status: Granted
- Kind: B2
- Application number: 16/721,696
- Filed: 2019-12-19
- Published: 2020-06-18
- Granted: 2024-05-28
- Earliest claimed: 2010-07-29
- Assignees: Roche Molecular Systems, Inc.
- Applicants: Roche Molecular Systems, Inc.
- Inventors: Sean F. Boyle; Meike Eickhoff; Christopher Newhouse; Eberhard Russmann; Edward S. Smith; Andreas Woelfelschneider; Dirk Zimmermann
- Web page: https://patentgrep.com/patent/US11993804B2

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention relates to the sample preparation of nucleic acids for diagnostic purposes. More precisely, the invention provides a process for simultaneously isolating at least a first and a second target nucleic acid from a plurality of different types of fluid samples and optionally amplifying said isolated nucleic acids in a simultaneous manner.

## Claims

### Claim 1

A process for simultaneously amplifying a first target nucleic acid and a second target nucleic acid from a plurality of different types of fluid samples, wherein the first target nucleic acid is a nucleic acid from bacteria and the second nucleic acid is a nucleic acid from DNA viruses or RNA viruses or the first nucleic acid is a nucleic acid from the DNA viruses or the RNA viruses and the second target nucleic acid is a nucleic acid from the bacteria and the process comprises following automated steps:
(a) adding an identical lysis buffer to the plurality of different types of fluid samples, thereby releasing nucleic acids from the bacteria, the DNA viruses, and the RNA viruses by lysing the bacteria, the DNA viruses, and the RNA viruses present in the plurality of different types of fluid samples, and combining together magnetic particles and the nucleic acids released from the bacteria, the DNA viruses, and the RNA viruses for a period of time and under conditions sufficient to permit the nucleic acids to be immobilized on the magnetic particles, wherein the lysis buffer comprises a chaotropic agent, a buffer substance, an alcohol, and a reducing agent, and has a pH between 5.5 and 6.5, and the nucleic acids comprise the first target nucleic acid and the second target nucleic acid;
(b) isolating the magnetic particles of step (a) from other materials present in the different types of fluid samples in a separation station, thereby producing isolated magnetic particles, wherein the separation station comprises one or more magnets;
(c) on the separation station, washing the isolated magnetic particles by adding a wash buffer to the isolated magnetic particles in vessels and dispensing suspensions comprising the wash buffer and the separated magnetic particles one or more times in the vessels using a pipet;
(d) obtaining purified nucleic acids by eluting the nucleic acids from the magnetic particles obtained from step (c) with an elution buffer;
(e) transferring the purified nucleic acids to a plurality of reaction vessels; and
(f) simultaneously amplifying the first target nucleic acid and the second target nucleic acid from the purified nucleic acid in the plurality of reaction vessels,
wherein the period of time and conditions of step (a) are identical for the plurality of different types of fluid samples.

### Claim 2 (depends on 1)

The process of claim 1, wherein the plurality of reaction vessels are combined in the same integral arrangement.

### Claim 3 (depends on 1)

The process of claim 1, wherein the first target nucleic acid is RNA, and the second target nucleic acid is DNA.

### Claim 4 (depends on 1)

The process of claim 1, wherein step (a) is carried out at a temperature up to 50° C.

### Claim 5 (depends on 1)

The process of claim 1, wherein step (d) is carried out at a temperature between 70° C. and 90° C.

### Claim 6 (depends on 1)

The process of claim 1, wherein step (f) includes following steps:
(i) contacting the purified nucleic acids with one or more amplification reagents comprising a polymerase with reverse transcriptase activity in at least two reaction vessels of the plurality of reaction vessels, wherein at least a first reaction vessel of the at least two reaction vessels comprises the first target nucleic acid, and at least a second reaction vessel of the at least two reaction vessels comprises the second target nucleic acid, and wherein the second target nucleic acid is absent from the first reaction vessel and both the first target nucleic acid and the second target nucleic acid in the at least two reaction vessels are RNAs; and
(ii) incubating the purified nucleic acids with the one or more amplification reagents in the at least two reaction vessels for a period of time and under conditions suitable for transcription of RNAs by the polymerase with reverse transcriptase activity,
wherein the conditions for incubating the purified nucleic acids with the one or more amplification reagents in the at least two reaction vessels.
